- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
James P. Brogan (Jim)
News 13 results
In the News · Source: BusinessDen
In the News · Source: Law360, Reuters, The AmLaw Litigation Daily, Global Legal Chronicle and Global Competition Review
In the News · Source: Berkeley Center for Law and Technology's Expert Series Podcast
August 23, 2021
Abby Parsons and Jim Brogan appear on UC Berkeley Law’s Expert Series Podcast to discuss the DUSA Pharmaceuticals, Inc. v. Biofrontera Inc. case
Recognition
August 2, 2021
Managing IP Again Recommends Multiple King & Spalding IP Practices, Individuals in its Annual Guide
Events 3 results
Webinar
March 30, 2022
Maximizing Contract and Treaty-Based Protections For Cross-Border Transactions in the Pharmaceutical Industry
Conference
September 5, 2019
12th Annual Medical Device Summit
Conference
June 21, 2018
West Coast Pharmaceutical & Medical Device University
Insights 1 results
Client Alert
March 24, 2022
Potential Remedies for Russia’s Suspension of Foreign Investors’ Intellectual Property Rights